The Mount Sinai Hospital
Based in NY
🤖
AI Overview
With $3.6M in lobbying spend across 32 quarterly filings, The Mount Sinai Hospital is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
$3.6M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $810K |
| 2019 | $360K |
| 2020 | $290K |
| 2021 | $420K |
| 2022 | $260K |
| 2023 | $480K |
| 2024 | $380K |
| 2025 | $610K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Taxation, MED, Homeland Security and 1 more
- •H.R.; An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; Provisions related to tax implications for higher education, pat
- •Issues related to HOPD rate cuts.
- •Issues related to the 340B program.
- •Issues related to organ transplantation equity.
- •Issues related to the FDA regulation of laboratory developed tests.
- •Issues rel
- •Issues related to HOPD rate cuts.
- •Issues related to the 340B program.
- •Issues related to organ transplantation equity.
- •Issues related to the FDA regulation of laboratory developed tests.
- •Issues related
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.